Please disable your Ad Blocker to better interact with this website.

News Clash

BIG PHARMA FIGHT: Pfizer Jab Makers Facing New IP Lawsuit Over mRNA Tech

Become a Clash Insider!

Don’t let Big Tech pre-chew your news. Sign up for our free email newsletter, and we’ll keep you in the loop.

You may not have heard the name CureVac, but as of today, a lot of people will take a serious interest in it. Why?

Because they just launched a lawsuit against both companies in the partnership that gave us their COVID vaccine: Comirnaty® by BioNTech and its partner Pfizer

CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”) today announced that it has moved to assert its intellectual property rights, accumulated over more than two decades of pioneering work in mRNA technology, which contributed to COVID-19 vaccine development. CureVac has filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech SE and two of its subsidiaries, seeking fair compensation for infringement of a portfolio of CureVac’s intellectual property rights…

The CureVac intellectual property portfolio protects multiple inventions that are considered essential to the design and development of BioNTech’s SARS CoV-2 mRNA vaccine, among others. These relate to the engineering of mRNA molecules, including sequence modifications to increase stability and enhance protein expression, as well as mRNA vaccine formulations specific to SARS CoV-2 vaccines.

Over the last 22 years, CureVac developed proprietary foundational technology related to mRNA design, delivery and manufacturing that materially contributed to the development of safe and efficacious COVID-19 vaccines. CureVac considers the rapid development of these vaccines a tremendous achievement, with unprecedented positive impact for global public health. This achievement is based on decades of scientific research and innovation, supported by CureVac as the earliest pioneer in mRNA technology. Accordingly, CureVac’s intellectual property rights need to be acknowledged and respected in the form of a fair compensation to reinvest into the further advancement of mRNA technology and the ongoing development of new classes of life saving medicines. —AccessWire

So, can it be that the company that cornered the market on global vaccines and has been making truckloads of profit off the mRNA vaccine wasn’t even using their own technology to do it?

Whether the plaintiffs win their case and get compensated for use of their proprietary tech could have some serious financial impact on everyone who has been invested in the companies that gave us the jab in the first place.

Dear Christian: Your Fear Is Full of Crap

by Doug Giles

Beginning in March 2020, many Christians went into lockdown-freak-out mode.

They “socially distanced” themselves from corporate worship and from pretty much everyone and everything else, except, of course, liquor, and grocery stores.

Uncut, irrational, unbiblical, and not to mention, unconstitutional, fear gripped many churches and church leaders.

Should pastors publicly repent if they obeyed Fauci in regard to how they conducted their ministry instead of adhering to the clear commands of the King of Kings and Lord of Lords?

That’s a legit question, eh?

Get your copy of Dear Christian: Your Fear Is Full of Crap now. Better yet, grab an extra copy for any petrified pastor who dutifully put obedience to the unconstitutional edicts of Mayor McCheese ahead of obedience to the explicit commandments of the LORD God Almighty.

Wes Walker

Wes Walker is the author of "Blueprint For a Government that Doesn't Suck". He has been lighting up since its inception in July of 2012. Follow on twitter: @Republicanuck

Related Articles